Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00221390Phase 2Completed
Phase 2, randomised, double-blind trial in stroke comparing Ropinirole + physical therapy with Placebo + physical therapy (2 arms). Primary endpoint: Gait velocity at 12 weeks. Started Oct 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00221390.